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Abstract 
Antihyperglycaemic effect of aqueous root extract of male Carica papaya L. (Family: Caricaceae) was 
investigated in alloxan-induced albino rats. 500 mg/kg body weight extract was administered by gavage orally 
twice daily for 7 days. Consequent upon induction of diabetes, the resulting raised levels of blood glucose, 
cholesterol, bilirubin, alanine aminotransferase (ALT) and alkaline phosphatase (AP) were significantly (p<0.05) 
reduced after one week of administering the extract. In contrast, the significant decrease in total plasma protein of 
rats injected with alloxan were significantly (p<0.05) increased following administration of extract compared to 
diabetic control rats. The results indicate the aqueous extract of male Carica papaya root ameliorated 
hyperglycaemia and hypercholesterolaemia lending credence to its folkloric use as treatment for diabetes mellitus. 
Furthermore, the extract ameliorated hepatic tissue injuries in the diabetic rats.  
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1. Introduction  
Diabetes mellitus is a chronic disorder of carbohydrate, fat and protein metabolism. A relative or absolute 
deficiency in insulin secretory response, which translates into carbohydrate (glucose) use, is a characteristic feature 
of diabetes (James et al., 2003). One type of classification was proposed in 1997 by the American Diabetes 
Association based on etiology. These are diabetes types 1 and 2. Type 1 diabetes formerly called Insulin-
Dependent Diabetes Mellitus (IDDM) or juvenile onset diabetes accounts for 5% to 10% of all cases of diabetes. 
In type 2 diabetes, up to 80% of patients are involved. It was previously called Non-Insulin-Dependent Diabetes 
mellitus (NIDDM) or adult onset diabetes (Frier & Fisher, 2002). Long term complications include retinal damage, 
nerve damage, microvascular disease, cardiovascular disease, liver damage, renal failure etc. if the disease is not 
adequately controlled.  
Epidemiological survey indicated that diabetes mellitus, among other debilitating pathologic conditions, is 
the leading cause of morbidity and mortality of all age groups worldwide (Matough et al., 2012). The World Health 
Organisation in the year 2000 reported that 2.8% of the global population was afflicted with diabetes mellitus and 
epidemiological projections showed that the number is expected to rise to 4.4% by the year 2030 (Wild et al., 
2004). These statistics underscore the enormous public health concerns of diabetes mellitus. There is therefore a 
need to improve already established remedies and to develop new ones. In view of this, the WHO expert committee 
on diabetes mellitus (WHO, 1980) recommended that it is important to investigate the effect of agents of plant 
origin used in traditional medicine.  
Carica papaya L. (Family: Caricaceae) is a herbaceous dicotyledonous plant that may produce fruits for many 
years. The plant usually has a single trunk with several well developed branches. The melon-like fruits vary in size 
and shape, and hang from short thick peduncles at the leaf axel. Its flowers are mostly dioecious and resemble each 
other until they start to develop sexual organs. The species is polygamous and can be classified into three sex types: 
male staminate, hermaphrodite (bisexual) and female pistillate. A few male plants in a plantation help pollination 
and development of large fruits. The plant, originally a native of America is now extensively grown in all warm 
countries (Dutta, 1970).  
C. papaya more commonly known as papaw has been used as a diuretic (the roots and leaves), anthelmintic 
(the leaves and seeds) and fruits to treat bilious conditions. Parts of the plant are also used to combat dyspepsia 
and other digestive disorders (papaya contains proteolytic enzymes which soothes the stomach and aids digestion), 
and a liquid portion has been used to reduce enlarged tonsils (Oliver-Bever, 1980; Duke, 1985). In addition, the 
juice is used for warts, cancers, tumors, corns and skin defects while the root is said to help tumors of the uterus. 
This study aims at investigating the antidiabetic claims of the aqueous extract of male C. papaya root by studying 
indices of diabetes mellitus such as glucose, cholesterol as well as total protein, bilirubin and liver marker enzymes 
using albino rats. 
 
2. Materials and Methods  
2.1 Chemicals/Reagents 
Alloxan monohydrate was purchased from Sigma Chemical Company, St. Louis, MO, USA. Assay kits used in 
estimating glucose, cholesterol, total protein, bilirubin, alanine aminotransferase and alkaline phosphatase were 
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purchased from Randox Laboratory Ltd., UK.  
 
2.2 Animals  
Twenty-five (25) albino rats of the Sprague-Dawley strain weighing between 100 g and 230 g were purchased 
from the Nigerian Institute for Medical Research, Yaba, Lagos. They were housed in clean metal cages at a 
temperature of 25 ± 2 0C with 12 hours light/dark cycles. They were acclimatized for one week and fed on grower’s 
pellets (Bendel Feed Mill, Ewu, Edo State, Nigeria) and given water ad libitum. Animals were handled in 
accordance with internationally accepted principles for laboratory animal use and care (NIH Publication 85 – 93, 
revised, 1985).  
 
2.3 Induction of Diabetes Mellitus  
Diabetes mellitus was induced on two consecutive days by the intraperitoneal injection of freshly prepared 
100mg/kg body weight of alloxan monohydrate (Sigma Chemical Company, St. Louis, MO, USA) dissolved in 
distilled water. Twenty-four (24) hours after the second alloxan injection, fasting blood (16 h) was drained from 
the tail veins of conscious rats and analysed. Only rats with fasting blood glucose above 120 mg/dl were used for 
the diabetes study.  
 
2.4 Pharmacological Evaluation  
Twenty-five (25) rats were randomly divided into 3 groups with Groups A and B having ten (10) rats each and 
Group C five (5). 500 mg/kg body weight of the aqueous root extract of male Carica papaya was administered to 
Group B rats orally by gavage twice daily.  
Group A: Diabetic rats received distilled water (Diabetic control) 
Group B: Diabetic rats received C. papaya aqueous root extract (Diabetic treated)  
Group C: Normal rats received distilled water (Normal control) 
 
2.5 Plant Material and Extraction  
Fresh roots were collected from male Carica papaya growing in a garden at the University of Benin, Benin City, 
Nigeria and identified (Voucher Number UBHC342) at the Plant Biology and Biotechnology Department 
Herbarium of the same university. The roots were then washed under running tap water to remove soil and debris. 
They were cut into tiny pieces, sun-dried and oven-dried (Gallenkamp, UK) at 60 0C till a constant weight was 
recorded. The dried roots were milled (Thomas-Wiley Machine, England) and the sieved powdered sample kept 
in sealed glass bottles till needed.  
Exactly 250 g of the powdered root of C. papaya were extracted with 1.5 litres of distilled water in a soxhlet 
extraction apparatus for 8 hours. The liquid extract was concentrated using a rotary evaporator (Gallenkamp, UK) 
and the semi-solid dried extract was further dried to a constant weight over a steam bath (Gallenkamp, UK) at 60 
0C, giving a 8.4% yield. 5 g of the extract was made up to 100 ml and used as stock crude drug.  
 
2.6 Blood Collection  
Prior to blood collections, feed was withdrawn from all rats but were allowed water ad libitum. Fasting blood was 
drained from the veins of conscious rats into fluoride citrate treated bottles for glucose analysis and into lithium 
oxalate specimen bottles for plasma used for other analysis. Blood samples were collected prior to induction of 
diabetes (baseline), 24 hours after second alloxan injection and then on alternate days thereafter during 
administration of extract. Blood samples were centrifuged at 3,500 r.p.m. (MSE Minor Bench Centrifuge, London) 
for 10 min and serum/plasma analysed using assay kits from Randox Laboratory Ltd, UK.  
 
2.7 Biochemical Analysis  
Serum glucose concentration was estimated using enzymatic colorimetric kits (Randox Laboratory Ltd., UK) in 
which the glucose oxidase/peroxidase/4-aminophenazone method of Tietz (1990) was adopted. Absorbance was 
read at 500 nm (Pye Unicam SP 1800 Ultraviolet Spectrophotometer). Plasma cholesterol concentration was 
estimated as described in the Randox Kit where the indicator quinoneimine is formed from hydrogen peroxide and 
4-amino antipyrene in the presence of phenol and peroxidase. Absorbance was read at 500 nm. Bilirubin was 
determined by the reaction with diazolized sulfanilic acid and absorbances read at 578 nm. Plasma total protein 
was determined using the biuret method for detecting the presence of peptide bonds (Tietz, 1995). Briefly, 0.02 
ml of plasma, standard protein solution and reagent blank were pipetted into 3 different tubes and 1.0ml biuret 
reagent solution added. The mixture was incubated for 30 min at 25 0C and absorbance of the plasma and standard 
measured against the reagent blank at 546 nm.  
 
2.8 Assessment of Liver Enzymes  
The activities of plasma alanine aminotransferase (ALT) and alkaline phosphatase (AP) were assayed using 
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colorimetric assay kits (Randox Laborator Ltd., UK) according to manufacturer’s instructions and values 
expressed in IU/L. 
 
2.9 Statistical Analysis  
Results are presented as means ± SD of triplicate determinations. The differences between the means of test and 
control groups were analysed by student t-test. Statistical significance was set at a value of p ≤ 0.05. 
 
3. Results  
Results obtained are displayed in Tables 1 to 6. The blood glucose levels of rats before alloxan injection (Day 0, 
baseline values) and after (Days 3, 5, 7 and 9) are presented in Table 1.  
Administration of C. papaya lowered serum glucose concentration in the diabetic treated rats (Group B) 
compared to control and baseline values (p<0.05). Following one week administration of the extract, was a 56.65% 
decrease in serum glucose level compared with control rats (Group A).  
Table 1: Effect of male C. papaya aqueous root extract on serum glucose concentrations (mg/dl) in alloxan-induced 
diabetic rats. Treatment began on Day 3 
Day Diabetic Control 
Rats (Group A) 
Diabetic Treated 
Rats (Group B) 
Normal Control 
Rats (Group C) 
Significance  
Pre-alloxan      
0 74.64 ± 13.00a       
(7) 
82.50 ± 9.90b        
(9) 
74.14 ± 14.20c        
(5) 
ab p > 0.05 
ac p > 0.05 
Post-alloxan      
3 127.24 ± 42.00d       
(7) 
114.90 ± 13.40e        
(9) 
- ad p < 0.05 
be p < 0.05 
5 137.26 ± 33.6f       
 (7) 
88.50 ± 16.80g       
(9) 
69.90 ± 4.40h        
(5) 
fg p < 0.05 
fh p < 0.05 
7 121.26 ± 29.90i       
(7) 
72.30 ± 9.80j        
(9) 
65.00 ± 13.40k        
(5) 
ij p < 0.05 
ik p < 0.05 
9 96.87 ± 24.80l       
(7) 
59.50 ± 8.90m        
(9) 
67.74 ± 7.00n        
(5) 
lm p < 0.05 
ln p < 0.05 
(n) = number of rats. Values are means ± SD of triplicate determinations  
Table 2 shows the concentrations of plasma cholesterol in rats before and after treatments. Injection of rats 
with alloxan caused a significant increase (p < 0.05) in plasma cholesterol concentrations in the diabetic rats 
(Groups A and B) when compared to the normal control rats (Group C). Administration of the extract caused a 
significant (p <0.05) lowering of cholesterol levels in the treated diabetic rats.  
Table 2: Effect of male Carica papaya aqueous root extract on plasma cholesterol concentrations (mg/dl) in 
alloxan-induced diabetic rats. Treatment began on Day 3 
Day Diabetic Control 
Rats (Group A) 
Diabetic Treated 
Rats (Group B) 
Normal Control 
Rats (Group C) 
Significance  
Pre-alloxan      
0 69.74 ± 13.52a       
(7) 
73.70 ± 8.43b        
(9) 
74.16 ± 18.80c        
(5) 
ab p > 0.05 
ac p > 0.05 
Post-alloxan      
3 101.90 ± 22.30d       
(7) 
105.0 ± 9.93e        
(9) 
- ad p < 0.05 
be p < 0.05 
5 121.76 ± 22.30f       
(7) 
86.10 ± 7.52g        
(9) 
67.20 ± 14.90h        
(5) 
fg p < 0.05 
fh p < 0.05 
7 117.20 ± 19.90i       
(7) 
91.10 ± 3.04j        
(9) 
74.78 ± 8.40k        
(5) 
ij p < 0.05 
ik p < 0.05 
9 116.09 ± 17.70l       
(7) 
82.10 ± 9.34m        
(9) 
65.60 ± 7.30n        
(5) 
lm p < 0.05 
ln p < 0.05 
(n) = number of rats. Values are means ± SD of triplicate determinations  
Alloxan injection caused a statistically significant (p <0.05) decrease in total protein concentration in the rats 
(Table 3). 
Following one week oral administration of the extract, total protein concentration in the treated rats increased 
significantly (p < 0.05). 
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Table 3: Effect of male Carica papaya aqueous root extract on total protein concentrations (mg/dl) in alloxan-
induced diabetic rats. Treatment began on Day 3 
Day Diabetic Control 
Rats (Group A) 
Diabetic Treated 
Rats (Group B) 
Normal Control 
Rats (Group C) 
Significance  
Pre-alloxan      
0 10.70 ± 1.03a       (7) 12.40 ± 1.68b        
(9) 
11.40 ± 3.91c        
(5) 
ab p > 0.05 
ac p > 0.05 
Post-alloxan      
3 6.54 ± 1.69d       (7) 6.30 ± 1.02e        
(9) 
- ad p < 0.05 
be p < 0.05 
5 5.74 ± 1.00f       (7) 6.74 ± 1.21g        
(9) 
8.76 ± 1.91h        
(5) 
fg p > 0.05 
fh p < 0.05 
7 5.10 ± 1.30i       (7) 7.78 ± 1.79j        
(9) 
8.60 ± 1.66k        
(5) 
ij p < 0.05 
ik p < 0.05 
9 4.10 ± 1.45l       (7) 10.40 ± 1.60m        
(9) 
8.90 ± 1.73n        
(5) 
lm p < 0.05 
ln p < 0.05 
(n) = number of rats. Values are means ± SD of triplicate determinations  
Induction of diabetes mellitus significantly (p < 0.05) raised total plasma bilirubin concentrations. 
Administration of diabetic rats with the extract caused a 98.68% reduction after one week.  
Table 4: Effect of male Carica papaya aqueous root extract on plasma total bilirubin in alloxan-induced diabetic 
rats. Treatment began on Day 3 
Day Diabetic Control 
Rats (Group A) 
Diabetic Treated 
Rats (Group B) 
Normal Control 
Rats (Group C) 
Significance  
Pre-alloxan      
0 1.06 ± 0.23a       (7) 1.20 ± 2.50b        
(9) 
1.34 ± 0.18c        
(5) 
ab p > 0.05 
ac p > 0.05 
Post-alloxan     
3 2.73 ± 2.28d       (7) 3.80 ± 3.10e        
(9) 
- ad p < 0.05 
be p < 0.05 
5 2.04 ± 1.02f       (7) 1.40 ± 1.30g        
(9) 
1.10 ± 0.16h        
(5) 
fg p < 0.05 
fh p < 0.05 
7 1.65 ± 0.48i       (7) 0.04 ± 0.03j        
(9) 
1.26 ± 0.30k        
(5) 
ij p < 0.05 
ik p > 0.05 
9 1.46 ± 0.72l       (7) 0.05 ± 0.04m        
(9) 
1.16 ± 0.11n        
(5) 
lm p < 0.05 
ln p > 0.05 
(n) = number of rats. Values are means ± SD of triplicate determinations  
Tables 5 and 6 show the results for the effect of extract on some marker enzymes in liver disease. Alloxan 
induction caused significant increases (p < 0.05) in plasma Alanine aminotransferase (ALT) activities. 
Administration of extract caused a statistically significant (p < 0.05) reduction after one week. Plasma alkaline 
phosphatase (AP) activities also increased significantly (p< 0.05) upon alloxan induction. Administration of the 
extract elicited a 74.03% reduction after one week (Table 6).  
Table 5: Effect of male Carica papaya aqueous root extract on plasma Alanine aminotransferase activity (IU/L) 
in alloxan-induced diabetic rats. Treatment began on Day 3 
Day Diabetic Control 
Rats (Group A) 
Diabetic Treated 
Rats (Group B) 
Normal Control 
Rats (Group C) 
Significance  
Pre-alloxan      
  0 23.26 ± 11.20a       
(7) 
22.70 ± 1.30b        
(9) 
25.30 ± 5.80c        
(5) 
ab p > 0.05 
ac p > 0.05 
Post-alloxan     
3 28.04 ± 14.80d       
(7) 
29.40 ± 3.00e        
(9) 
- ad p < 0.05 
be p < 0.05 
5 28.84 ± 8.57f       (7) 29.80 ± 4.40g        
(9) 
17.34 ± 6.36h        
(5) 
fg p > 0.05 
fh p < 0.05 
7 29.24 ± 6.23i       (7) 25.30 ± 1.75j        
(9) 
18.90 ± 6.47k        
(5) 
ij p < 0.05 
ik p < 0.05 
9 29.76 ± 7.73l       (7) 20.40 ± 2.37m        
(9) 
20.06 ± 3.09n        
(5) 
lm p < 0.05 
ln p < 0.05 
(n) = number of rats. Values are means ± SD of triplicate determinations  
Journal of Natural Sciences Research                                                                                                                                                www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online)  
Vol.10, No.6, 2020 
 
5 
Table 6: Effect of male Carica papaya aqueous root extract on plasma alkaline phosphatase activity (IU/L) in 
alloxan-induced diabetic rats. Treatment began on Day 3 
Day Diabetic Control 
Rats (Group A) 
Diabetic Treated 
Rats (Group B) 
Normal Control 
Rats (Group C) 
Significance  
Pre-alloxan      
  0 40.89 ± 9.33a       (7) 41.30 ± 7.10b        
(9) 
36.98 ± 14.17c        
(5) 
ab p > 0.05 
ac p > 0.05 
Post-alloxan     
3 52.21 ± 8.74d       (7) 59.30 ± 3.30e        
(9) 
- ad p < 0.05 
be p < 0.05 
5 46.74 ± 7.34f       (7) 35.10 ± 13.90g        
(9) 
34.88 ± 12.08h        
(5) 
fg p < 0.05 
fh p < 0.05 
7 49.50 ± 6.55i       (7) 15.30 ± 3.30j        
(9) 
36.16 ± 11.08k        
(5) 
ij p < 0.05 
ik p < 0.05 
9 49.04 ± 4.60l       (7) 15.40 ± 0.40m        
(9) 
36.72 ± 11.91n        
(5) 
lm p < 0.05 
ln p < 0.05 
(n) = number of rats. Values are means ± SD of triplicate determinations  
 
4. Discussion  
From earliest of times, diabetes has been treated with plant remedies. The present study investigated the effects of 
male Carica papaya L. aqueous root extract on some biochemical indices in albino rats with the aim of 
scientifically establishing its ethnomedicinal use as an antidiabetic agent.  
The results obtained show that serum glucose concentration increased significantly (p < 0.05) when compared 
with basal and control values, thus confirming that animals used in this study were made diabetic by alloxan 
injection. Effective blood glucose control is the key for preventing or reversing diabetic complications (Marx, 
2002). The decrease in serum glucose levels following treatment with the extract essentially indicated the 
effectiveness of C. papaya as an antihyperglycaemic agent. This study thus corroborates the work of other 
researchers who have also reported antihyperglycaemic activities of some plants (Afolayan & Sunmonu, 2010; 
Nimenibo-Uadia & Nwachukwu, 2017).  
Cholesterol and other lipids such as triacylglycerols are raised in the diabetic state. The gradual reduction in 
cholesterol concentration on administration of the extract to diabetic rats shows C. papaya has 
antihypercholesterolaemic effects. Other workers have reported antihypercholesterolaemic/antihyperlipidaemic 
effects of some medicinal plants (Janapti, 2015; Nimenibo-Uadia & Nwachukwu, 2017).  
Decreases observed in protein concentration in the diabetic rats may be due to energy metabolism shifting 
from carbohydrate to other alternative sources such as protein and fat in a diabetic state. Also, protein synthesis 
by the liver may have been impaired due to damage of the liver by alloxan induction of diabetes.  
Reduced plasma total protein may occur due to impaired protein synthesis (as in case of malnutrition), liver 
disease among others (Whitby et al., 1984). The increase in protein concentrations following one week of treatment 
by the extract suggest the plant may have restored some functionality to the liver architecture.  
Hyperbilirubinaemia as seen in the diabetic animals is one of the conditions indicative of liver damage. The 
98.68% reduction in hyperbilirubinaemia observed after one week administration of the extract suggests C. papaya 
aqueous root extract may have repaired the damaged liver.  
Alanine aminotransferase (ALT) or Aspartate aminotransferase (AST) activity determinations are routine 
tests for hepatocellular integrity but plasma ALT (which we studied) is more liver-specific (Whitby et al., 1984). 
Alkaline phosphatase estimation is a routine test for presence of cholestasis in liver damage/disease. Its elevation 
following alloxan-induction of diabetes in rats in the present study, thus indicates liver damage. Cholestasis is 
most commonly due to extrahepatic obstruction of the bile ducts (Whitby et al., 1984). Following one week of 
therapy, there was a decrease in AP activity, thus confirming the healing effects of male C. papaya aqueous root 
extract on the liver.  
 
5. Conclusion  
The observations in this study have shown that male C. papaya aqueous root extract is able to ameliorate the 
biochemical defects indicative of diabetes mellitus. Most antidiabetic plants have been reported to contain saponins, 
alkaloids, flavonoids, tannins, glycosides that are usually implicated as possessing antidiabetic properties (Harbone 
et al., 1974; Oliver-Bever, 1980; Nimenibo-Uadia et al., 2017). Thus, the antidiabetic effects of male C. papaya 
aqueous root may be due to any of these bioactive metabolites.  
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